CICB scientists and trainees to present at the Alzheimer’s Association International Conference 2025

The Alzheimer’s Association International Conference (AAIC) is one of the largest scientific conferences on dementia research. This year’s meeting will be held July 27-31, 2025 in Toronto, Canada. Like previous years, several CICB-affiliated scientists and trainees will be presenting their cutting-edge research on Alzheimer’s disease and related dementias.

From the Bush lab:

Investigating the Shared Genetic Architecture Between Kidney Function and Alzheimer’s Disease Across Ancestries, to be presented by Biomedical Health Informatics (BHI) PhD candidate Diya Yang

Variant Modifies APOE Risk Effect in 5155 Non-Hispanic White and 4133 African Americans, to be presented by Systems Biology and Bioinformatics (SYBB) graduate student Yuchen Yang

From the Crawford lab:

Application of supervised and unsupervised machine learning approaches to identify somatic T-cell receptor sequence diversity profiles in Alzheimer disease among Midwestern Amish, to be presented by Epidemiology and Biostatistics (EPBI) PhD candidate Lauren Cruz

Dissecting Alzheimer Disease Heritability Across Dᴉverse Populations, to be presented virtually by EPBI PhD alumna and post-doctoral scholar Shiying Liu

Predicting Late-onset Alzheimer Disease (LOAD) following COVID-19 infection by using machine learning applications on real world data from the National Clinical Cohort Collaborative (N3C), to be presented by BHI PhD candidate Carly Rose

From the Haines lab:

Heterogeneity in the Genetic Architecture of Alzheimer disease (AD) across Ancestry Groups, to be presented by Research Associate Penny Benchek, PhD

Rare Variant Association Analysis Reveals B3GNT9, RANBP10, and C1QL4 As Potential Genes for Cognitive Preservation in the Mid-Western Amish, to be presented by SYBB PhD candidate Yining Liu

Investigating the effects of complement loci CFH and ARMS2/HTRA1 on Alzheimer Disease, to be presented by SYBB PhD candidate Noel Moore

Mosaic Loss of Chromosome Y and Plasma Aβ42/p-tau181 Ratio as Biomarkers for Alzheimer Disease in the Midwestern Amish, to be presented by CWRU Instructor Dr. Yeunjoo Song

Also presenting are

APOE4-Linked Gut Microbiome Alterations and Alzheimer’s Risk via the Gut-Brain Axis, to be presented virtually by AAIC Conference Fellowship awardee and EPBI graduate student Chenyu Liu mentored by CWRU Population and Quantitative Health Sciences Assistant Professor Dr. Liangliang Zhang

Posted in News and tagged .

Dana Crawford

Professor of Population and Quantitative Health Sciences and Associate Director of the Cleveland Institute for Computational Biology, with interest in pharmacogenomics, electronic health records, and diverse populations. Also, an avid foodie!